In univariate analyses, parameters related to a poorer prognosis include expression of NANOG, HOXA9, BMP8B and CCR6, and BLS-type DLBCL, along with well-known clinical features. This evidence concerns the gene BMP8B and diffuse large B-cell lymphoma.